Spots Global Cancer Trial Database for placebo capsule
Every month we try and update this database with for placebo capsule cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer | NCT03519230 | Ovarian Cancer | Pamiparib capsu... Placebo capsule | 18 Years - | BeiGene | |
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women | NCT02101970 | Breast Cancer | Omega-3 Fatty A... Placebo Capsule Diet and Exerci... | 45 Years - 70 Years | University of Kansas Medical Center | |
A Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients | NCT03866499 | NSCLC | BPI-7711 Gefitinib Placebo Tablet Placebo capsule | 18 Years - | Beta Pharma, Inc. | |
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302) | NCT01924195 | Non-small Cell ... | Anlotinib Placebo capsule | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer | NCT03519230 | Ovarian Cancer | Pamiparib capsu... Placebo capsule | 18 Years - | BeiGene | |
Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0302) | NCT01924195 | Non-small Cell ... | Anlotinib Placebo capsule | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer | NCT02029209 | Non-small Cell ... | Anlotinib Placebo Capsule | 18 Years - 70 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer | NCT03519230 | Ovarian Cancer | Pamiparib capsu... Placebo capsule | 18 Years - | BeiGene | |
The Effect of Green Tea and Vitamin C on Skin Health | NCT01032031 | Skin Cancer | Green tea + vit... Placebo capsule | 18 Years - 65 Years | University of Manchester | |
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer | NCT00859651 | Breast Cancer | Cholecalciferol Placebo capsule | 21 Years - | Columbia University | |
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer | NCT02195453 | Non-Small Cell ... | Yangzhengxiaoji... Placebo Capsule | 18 Years - 70 Years | Shandong Cancer Hospital and Institute | |
A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer | NCT01896479 | Medullary Thyro... | Cabozantinib (X... Cabozantinib (X... Placebo tablet Placebo capsule | 18 Years - | Exelixis |